WST - West Pharmaceutical Services, Inc.

NYSE - NYSE Delayed price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
2,886,900
2,886,900
2,831,600
2,146,900
1,839,900
Cost of revenue
1,750,700
1,750,700
1,655,800
1,379,100
1,234,200
Gross profit
1,136,200
1,136,200
1,175,800
767,800
605,700
Operating expenses
Research development
58,500
58,500
52,800
46,900
38,900
Selling general and administrative
316,900
316,900
362,800
302,000
272,700
Total operating expenses
375,400
402,200
423,500
360,900
311,600
Operating income or loss
760,800
734,000
752,300
406,900
294,100
Interest expense
7,900
7,900
7,200
6,800
4,700
Total other income/expenses net
-78,100
-51,300
3,800
1,200
2,400
Income before tax
679,900
679,900
748,900
401,300
291,800
Income tax expense
114,700
114,700
107,200
72,500
59,000
Income from continuing operations
585,900
585,900
661,800
346,200
241,700
Net income
585,900
585,900
661,800
346,200
241,700
Net income available to common shareholders
585,900
585,900
661,800
346,200
241,700
Basic EPS
-
-
8.89
4.68
3.27
Diluted EPS
-
-
8.67
4.57
3.21
Basic average shares
-
-
74,400
73,900
74,000
Diluted average shares
-
-
76,300
75,800
75,400
EBITDA
-
854,600
878,400
517,200
399,900